SynthesisInternal and emergency medicine2026
The role of point-of-care ultrasound in the evaluation and management of hyponatremia: a systematic review.
Synthesis in Internal and emergency medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Hyponatremia is the most common electrolyte disorder. Accurate assessment of extracellular fluid volume status (hypovolemic, euvolemic, or hypervolemic) is essential for determining the underlying etiology and guiding treatment. Point-of-care ultrasound (PoCUS) has emerged as a complementary bedside tool to objectively assess volume status in hyponatremia. We systematically reviewed the relevant literature up to June 2025. The aim of this systematic review was to evaluate the role of PoCUS in the assessment and management of hyponatremia. The evidence suggests that combined lung, cardiac, and abdominal PoCUS (including the venous excess ultrasound score, VExUS) helps overcome the limitations of physical examination. PoCUS leads to a more accurate etiologic diagnosis and optimized treatment. PoCUS also aids in monitoring treatment response, enabling real-time adjustment of diuretics or fluids based on serial examinations. Its role may be limited by operator dependency and inability to detect non-ultrasound-revealed pathologies such as hypothyroidism. Integrating bedside ultrasound into hyponatremia management improves volume assessment accuracy and supports a more individualized approach. Although current evidence is mainly derived from small studies and case series, findings consistently support using PoCUS as an adjunct to traditional evaluation.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.